Carregant...
Strategies For Targeting Chronic Myeloid Leukaemia Stem Cells
Chronic Myeloid Leukaemia is a myeloproliferative disorder driven by the t(9;22) chromosomal translocation coding for the chimeric protein BCR-ABL. CML treatment represents the paradigm of molecular therapy of cancer. Since the development of the tyrosine kinase inhibitor of the BCR-ABL kinase, the...
Guardat en:
| Publicat a: | Blood Lymphat Cancer |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Dove
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6842740/ https://ncbi.nlm.nih.gov/pubmed/31807112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/BLCTT.S228815 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|